Platelet-derived Growth Factor (PDGF) and PDGF Receptor Expression and Function in Folliculostellate Pituitary Cells

Abstract

Homo- and heterodimers of platelet-derived growth factor-A (PDGF-A) and PDGF-B chains are involved through PDGF α- and β-receptors in the growth regulation of multiple normal and tumoural cell types as well as in tumour neovascularization. Since little information is available on the impact of PDGF/PDGF receptors in normal and adenomatous pituitary, we studied the expression and action of this growth factor system in a variety of pituitary tumour cell lines and in rat anterior pituitary cell cultures. By RT-PCR, mRNA expression of PDGF-A and -B chains and of both receptors was found in rat pituitary and mouse folliculostellate TtT/GF pituitary tumour cells. Rat somatotroph MtT-S and mouse corticotroph AtT20 tumor cells expressed only a part of the PDGF/PDGF receptor components whereas mouse gonadotroph αT3-1 and rat lactosomatotroph GH3 pituitary tumour cells contained neither PDGF nor PDGF receptors. To further characterize the role of PDGF in TtT/GF cells, the effect of PDGF-AB and -BB on growth and vascular endothelial growth factor-A (VEGF-A) release was studied. Proliferation of TtT/GF cells was weakly but significantly stimulated by PDGF. Both in rat pituitary cell cultures and in TtT/GF cells, PDGF-AB and -BB strongly enhanced VEGF-A secretion. The PI3 kinase inhibitor LY 294002 blocked the increase in VEGF-A. Western immunoblotting confirmed the participation of key components of the PI3 kinase/Akt signal pathway (PDK1, Akt-Ser476) in PDGF-stimulated VEGF production. Thus the PDGF/PDGF receptor system is expressed in folliculostellate cells and is involved in VEGF regulation. Its role in endocrine pituitary tumour cell lines and pituitary adenomas need to be clarified in future studies.

Platelet-derived growth factor - PDGF receptors - folliculostellate cells - vascular endothelial growth factor - PI3 kinase/Akt pathway

References

• 1 Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.  J Clin Invest. 2003;  112 1142-1151
• 2 Alexander JM, Biller BM, Bikkal H. et al . Clinically nonfunctioning pituitary tumors are monoclonal in origin.  J Clin Invest. 1990;  86 336-340
• 3 Asa SL, Ezzat S. The pathogenesis of pituitary tumours.  Nat Rev Cancer. 2002;  2 836-849
• 4 Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice.  Cytokine Growth Factor Rev. 2004;  15 215-228
• 5 Board R, Jayson GC. Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics.  Drug Resist Updat. 2005;  8 75-83
• 6 Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis.  Tumori. 2004;  90 2-8
• 7 Carvalho I, Milanezi F, Martins A. et al . Overexpression of platelet-derived growth factor receptor a in breast cancer is associated with tumour progression.  Breast Cancer Res. 2005;  7 R788-R795
• 8 Chiang GG, Abraham RT. Targeting the mTOR signaling network in cancer.  Trends Mol Med. 2007;  13 433-442
• 9 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanat-phenol-chloroform extraction.  Anal Biochem. 1987;  162 156-159
• 10 Distler JH, Hirth A, Kurowska-Stolarska M. et al . Angiogenic and angiostatic factors in the molecular control of angiogenesis.  Q J Nucl Med. 2003;  47 149-161
• 11 Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents.  Nat Rev Drug Discov. 2006;  5 671-688
• 12 Farnoud MR, Kujas M, Derome P. et al . Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas.  Virchows Arch. 1994;  424 75-82
• 13 Fauquier T, Lacampagne A, Travo P. et al . Hidden face of the anterior pituitary.  Trends Endocrinol Metab. 2002;  13 304-309
• 14 Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.  Biochem Biophys Res Commun. 1989;  161 851-858
• 15 Frederiksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms.  Cytokine Growth Factor Rev. 2004;  15 197-204
• 16 Guo P, Hu B, Gu W. et al . Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.  Am J Pathol. 2003;  162 1083-1093
• 17 Heinrich MC, Corless CL, Duensing A. et al . PDGFRA activating mutations in gastrointestinal stromal tumors.  Science. 2003;  299 708-710
• 18 Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor.  Physiol Rev. 1999;  79 1283-1316
• 19 Höpfner M, Schuppan D, Scherübl H. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer.  World J Gastroenterol. 2008;  14 1-14
• 20 Homsi J, Daud AI. Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors.  Cancer Control. 2007;  14 285-294
• 21 Inoue K, Couch EF, Takano K. et al . The structure and function of folliculo-stellate cells in the anterior pituitary gland.  Arch Histol Cytol. 1999;  62 205-218
• 22 Inoue K, Hattori M, Sakai T. et al . Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen.  Endocrinology. 1990;  126 2313-2320
• 23 Lederle W, Stark H-J, Skobe M. et al . Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.  Am J Pathol. 2006;  169 1767-1783
• 24 Leon SP, Carroll RS, Dashner K. et al . Messenger ribonucleic acid expression of platelet-derived growth factor subunits and receptors in pituitary adenomas.  J Clin Endocrinol Metab. 1994;  79 51-55
• 25 Lohrer P, Gloddek J, Hopfner U. et al . Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.  Neuroendocrinology. 2001;  74 95-105
• 26 Maher EA, Furnari FB, Bachoo RM. et al . Malignant glioma: genetics and biology of a grave matter.  Genes Dev. 2001;  15 1311-1333
• 27 Onofri C, Theodoropoulou M, Losa M. et al . Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.  J Endocrinol. 2006;  191 249-261
• 28 Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.  Cytokine Growth Factor Rev. 2004;  15 275-286
• 29 Ray D, Melmed S. Pituitary cytokine and growth factor expression and action.  Endocr Rev. 1997;  18 206-228
• 30 Renner U, Lohrer P, Schaaf L. et al . Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells.  Endocrinology. 2002;  143 3759-3765
• 31 Renner U, Newton CJ, Pagotto U. et al . Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation.  Endocrinology. 1995;  136 3186-3193
• 32 Renner U, Paez-Pereda M, Arzt E. et al . Growth factors and cytokines: function and molecular regulation in pituitary adenomas.  Front Horm Res. 2004;  32 96-109
• 33 Sasahara M, Sato H, Iihara K. et al . Expression of platelet-derived growth factor B-chain in the mature rat brain and pituitary gland.  Brain Res Mol Brain Res. 1995;  32 63-74
• 34 Seeliger H, Guba M, Kleespies A. et al . Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis.  Cancer Metastasis Rev. 2007;  26 611-621
• 35 Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth.  Nature. 2006;  441 424-430
• 36 Simon MP, Pedeutour F, Sirvent N. et al . Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.  Nat Genet. 1997;  15 95-98
• 37 Smits A, Funa K, Vassbotn FS. et al . Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin.  Am J Pathol. 1992;  140 639-648
• 38 Steer EJ, Cross NC. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.  Acta Haematol. 2002;  107 113-122
• 39 Sullivan NJ, Tashjian Jr AH. Platelet-derived growth factor selectively decreases prolactin production in pituitary cells in culture.  Endocrinology. 1983;  113 639-645
• 40 Tallquist M, Kazlauskas A. PDGF signaling in cells and mice.  Cytokine Growth Factor Rev. 2004;  15 205-213
• 41 Tammela T, Enholm B, Alitalo K. et al . The biology of vascular endothelial growth factors.  Cardiovasc Res. 2005;  65 550-563
• 42 Taniguchi Y, Morita I, Kubota T. et al . Human uterine myometrial smooth muscle cell proliferation and vascular endothelial growth-factor production in response tp platelet-derived growth factor.  J Endocrinol. 2001;  169 79-86
• 43 Theodoropoulou M, Zhang J, Laupheimer S. et al . Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression.  Cancer Res. 2006;  66 1576-1582
• 44 Ueta Y, Levy A, Chowdrey HS. et al . S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas.  J Neuroendocrinol. 1995;  7 467-474
• 45 Vlotides G, Cruz-Soto M, Rubinek T. et al . Mechanism for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.  Mol Endocrinol. 2006;  20 3321-3335
• 46 Yeh HJ, Silos-Santiago I, Wang YX. et al . Developmental expression of the platelet-derived growth factor alpha-receptor gene in mammalian central nervous system.  Proc Natl Acad Sci USA. 1993;  90 1952-1956

Correspondence